» Articles » PMID: 35938504

Network Pharmacology and Experimental Evidence Reveal the Protective Mechanism of Yi-Qi Cong-Ming Decoction on Age-related Hearing Loss

Overview
Journal Pharm Biol
Specialties Pharmacology
Pharmacy
Date 2022 Aug 8
PMID 35938504
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Yi-Qi Cong-Ming (YQCM) decoction has been widely used to prevent age-related hearing loss (ARHL), the most prevalent neurodegenerative disease in the elderly.

Objective: To explore the mechanism of YQCM decoction in the treatment of ARHL.

Materials And Methods: The chemical constituents of YQCM were screened from the Traditional Chinese Medicine Systems Pharmacology Database. Potential targets of YQCM against ARHL were predicted by DrugBank, GeneCards, and OMIM database. Protein-protein network and enrichment analysis were used for exploring possible molecular mechanisms. Molecular docking and an model of ARHL by exposing auditory cells with 100 μM HO for 3 h were applied. Cell viability and mitochondrial membrane potential (ΔΨM) were detected by CCK-8 and high-content analysis. γH2AX and cleaved caspase-3 were detected by Western blot.

Results: The main compounds have good affinities with hub targets, especially AKT1, PTGS2, and CASP3. GO and KEGG analysis showed that the main biological process and key targets were related to negative regulation of the apoptotic process. HO treatment could reduce the cell viability by 68% and impaired ΔΨM, while 90 μg/mL YQCM pre-treatment could restore the cell viability by 97.45% and increase ΔΨM (2-fold higher). YQCM pre-treatment also reduced γH2AX and cleaved caspase-3 protein levels.

Conclusions: Our study suggested that YQCM prevents ARHL by modulating the apoptosis process in auditory hair cells. Moreover, this study proved that bioinformatics analysis combined with molecular docking and cell model is a promising method to explore other possible pharmacological interventions of ARHL.

Citing Articles

Age-related hearing loss: An updated and comprehensive review of the interventions.

Tavanai E, Rahimi V, Khalili M, Falahzadeh S, Zarandy M, Mohammadkhani G Iran J Basic Med Sci. 2024; 27(3):256-269.

PMID: 38333758 PMC: 10849199. DOI: 10.22038/IJBMS.2023.72863.15849.


Traditional Chinese medicine for the prevention and treatment of presbycusis.

Yan L, Huo Y, Shi J, Dong Y, Tan H Heliyon. 2023; 9(12):e22422.

PMID: 38076135 PMC: 10703638. DOI: 10.1016/j.heliyon.2023.e22422.


Mechanistic exploration of Yiqi Liangxue Shengji prescription on restenosis after balloon injury by integrating metabolomics with network pharmacology.

Mao T, Xie L, Guo Y, Ji X, Wan J, Cui X Pharm Biol. 2023; 61(1):1260-1273.

PMID: 37602438 PMC: 10443980. DOI: 10.1080/13880209.2023.2244533.

References
1.
Choi B, Lim D, Lee J, Gao S, Kwon D, Kim B . Luteolin suppresses cisplatin-induced apoptosis in auditory cells: possible mediation through induction of heme oxygenase-1 expression. J Med Food. 2008; 11(2):230-6. DOI: 10.1089/jmf.2007.591. View

2.
Sharma N, Tan M, An S . Phytosterols: Potential Metabolic Modulators in Neurodegenerative Diseases. Int J Mol Sci. 2021; 22(22). PMC: 8618769. DOI: 10.3390/ijms222212255. View

3.
Zhang Y, Lv Z, Liu Y, Cao H, Yang J, Wang B . PIN1 Protects Hair Cells and Auditory HEI-OC1 Cells against Senescence by Inhibiting the PI3K/Akt/mTOR Pathway. Oxid Med Cell Longev. 2021; 2021:9980444. PMC: 8273041. DOI: 10.1155/2021/9980444. View

4.
Maier J, Martinez C, Kasavajhala K, Wickstrom L, Hauser K, Simmerling C . ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J Chem Theory Comput. 2015; 11(8):3696-713. PMC: 4821407. DOI: 10.1021/acs.jctc.5b00255. View

5.
Tavanai E, Mohammadkhani G . Role of antioxidants in prevention of age-related hearing loss: a review of literature. Eur Arch Otorhinolaryngol. 2016; 274(4):1821-1834. DOI: 10.1007/s00405-016-4378-6. View